(19)
(11) EP 4 222 273 A1

(12)

(43) Date of publication:
09.08.2023 Bulletin 2023/32

(21) Application number: 21786189.7

(22) Date of filing: 29.09.2021
(51) International Patent Classification (IPC): 
C12N 15/88(2006.01)
A61K 47/69(2017.01)
 A61K 47/66(2017.01)
(52) Cooperative Patent Classification (CPC):
A61K 47/6901; C12N 15/88; A61K 48/0041; C07K 14/70596; C07K 14/4702; C07K 14/7151; C07K 14/5412; C07K 2319/00; C07K 2319/31; A61K 9/5068
(86) International application number:
PCT/EP2021/076845
(87) International publication number:
WO 2022/069577 (07.04.2022 Gazette 2022/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 29.09.2020 GB 202015399

(71) Applicant: Evox Therapeutics Ltd
Oxford OX4 4HG (GB)

(72) Inventors:
  • GUPTA, Dhanu
    141 57 Huddinge (SE)
  • EL ANDALOUSSI, Samir
    141 57 Huddinge (SE)
  • WIKLANDER, Oscar
    141 57 Huddinge (SE)
  • NORDIN, Joel
    141 57 Huddinge (SE)

(74) Representative: Cooley (UK) LLP 
22 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)

   


(54) ENGINEERED EXTRACELLULAR VESICLES DISPLAYING ENHANCED PHARMACOKINETICS